Wednesday, October 19, 2011: 12:00 PM-2:30 PM
1.1
The Relationship of Iron Status to Symptom Severity, Sleep-Related Limb Movements, and Cognitive Deficits in Children with and without ADHD
Rhoda J. Gottfried, M.D.
Johns Hopkins University School of Medicine, Baltimore, MD
Mark A. Riddle, M.D.
Johns Hopkins University School of Medicine, Baltimore, MD
Kyla Machell, B.A.
Johns Hopkins University, Baltimore, MD
E. Mark Mahone, Ph.D.
Kennedy Krieger Institute, Baltimore, MD
1.2
Efficacy of Treatment with Atomoxetine for Attention in Children and Adolescents with ADHD and Comorbid Dyslexia
Linda Wietecha, M.S., R.N.
Eli Lilly and Company, Indianapolis, IN
David Williams, M.S.C.
i3 Statprobe, Indianapolis, IN
Sally Shaywitz, M.D.
Yale School of Medicine, New Haven, CT
Bennett Shaywitz, M.D.
Yale School of Medicine, New Haven, CT
Stephen Hooper, Ph.D.
Carolina Institute for Developmental Disabilities (CIDD), University of North Carolina School of Medicine, Carrboro, NC
Sharon B. Wigal, Ph.D.
University of California, Irvine, Irvine, CA
David W. Dunn, M.D.
Indiana University School of Medicine, Indianapolis, IN
Keith McBurnett, Ph.D.
University of California, San Francisco, San Francisco, CA
1.3
Weiss Functional Impairment Rating Scale-Parent Report Outcomes From a Dose-Optimization Study of AM and PM Once-Daily Dosing with Guanfacine Extended Release in Children with ADHD
Margaret Weiss, M.D., FRCPC, Ph.D.
University of British Columbia, Vancouver, BC
Carla White
Shire Pharmaceuticals Inc., Basingstoke United Kingdom
Gail Enright, M.E.
Shire Development Inc., Wayne, PA
Vanja Sikirica, M.P.H., Pharm.D.
Shire Pharmaceuticals Inc., Wayne, PA
Sharon Youcha, M.D.
Shire Development Inc., Wayne, PA
1.4
A Meta-Analysis of Studies Examining Response Inhibition According to the Go/No-Go Task in ADHD and Other Psychiatric Disorders
Sathees W. Thayapararajah, M.D.
The Hospital for Sick Children, Toronto, ON
Jonathan Lipszyc, M.S.
The Hospital for Sick Children, Toronto, ON
Russell J. Schachar, M.D., FRCPC
The Hospital for Sick Children, Toronto, ON
1.5
Remittance of ADHD From Preschool to School Age: The Contribution of Effortful Control
Brittany L. Bascetta, B.S.
The Graduate Center, City University of New York, New York, NY
Sarah O'Neill, Ph.D.
Queens College of the City University of New York, Flushing, NY
David Marks, Ph.D.
Mount Sinai Medical Center, New York, NY
Jeffrey M. Halperin, Ph.D.
Queens College of the City University of New York, Flushing, NY
1.6
Do Executive Function Deficits Predict Parenting Stress in Parents of Children Diagnosed with ADHD?
Alan McLuckie, M.S.W.
Dalhousie University, Halifax, NS
David Ng, M.D.
Scarborough Hospital, University of Toronto, Toronto, ON
Michael Schwartz, Ph.D.
Psychologist in Private Practice, Toronto, ON
Melissa Rowbotham, M.A.
Integra Foundation for Learning Disabilities, Toronto, ON
Jessica Wishart, B.A.
Izaak Walton Killam Health Centre, Dalhousie University, Halifax, ON
1.7
Response of ADHD Symptoms in Children and Adolescents Treated With Guanfacine Extended Release Adjunctive to a Psychostimulant
Gregory Mattingly, M.D.
Washington University School of Medicine in St. Louis, Saint Charles, MO
Keith McBurnett, Ph.D.
University of California, San Francisco, San Francisco, CA
Sharon Youcha, M.D.
Shire Development Inc., Wayne, PA
Carla White
Shire Pharmaceuticals Inc., Basingstoke United Kingdom
Jonathan Rubin, M.D., M.B.A.
Shire Pharmaceuticals Inc., Wayne, PA
1.10
Influence of General Anxiety Disorder, State Anxiety, and Depressive Symptoms on Executive Function in Children with ADHD
Marco Armando, M.D.
IRCCS Ospedale Pediatrico Bambino Gesù, Rome Italy
Carmen Napolitano, Psy.D.
IRCCS Ospedale Pediatrico Bambino Gesù, Rome Italy
Marta Calcagni, Psy.D.
IRCCS Ospedale Pediatrico Bambino Gesù, Rome Italy
Maria Pia Casini, M.D.
IRCCS Ospedale Pediatrico Bambino Gesù, Rome Italy
Deny Menghini, Psy.D.
IRCCS Ospedale Pediatrico Bambino Gesù Italy
Stefano Vicari, M.D.
IRCCS Ospedale Pediatrico Bambino Gesù, Rome Italy
1.11
Pharmacokinetics of NWP06, a Novel Extended-Release Methylphenidate Oral Suspension in Children and Adolescents with ADHD
Sally A. Berry, M.D., Ph.D.
NextWave Pharmaceuticals, Inc, Cupertino, CA
Heidi Belden, Pharm.D.
NextWave Pharmaceuticals, Inc, Cupertino, CA
1.12
Cerebellar Symptoms and Balance Impairment Are More Prevalent in ADHD Children Compared to Healthy Controls
Michal Goetz, M.D.
Charles University in Prague, 2nd Faculty of Medicine, Prague Czech Republic
Jaroslava Schwabova, M.D.
Charles University in Prague, 2nd Faculty of Medicine, Prague Czech Republic
Alice Maulisova, Psy.D.
Charles University in Prague, 2nd Faculty of Medicine, Prague Czech Republic
Marie Hladikova, M.S.
Charles University in Prague, 2nd Faculty of Medicine, Prague Czech Republic
Petr Herman, M.S.C.
Charles University in Prague, 2nd Faculty of Medicine, Prague Czech Republic
Eliska Mlynarova, M.D.
Charles University in Prague, 2nd Medical Faculty, Prague Czech Republic
Marie Kaluzova, M.D.
Charles University in Prague, 2nd Medical Faculty, Prague Czech Republic
Vladimir Hort, M.D., Ph.D.
Charles University in Prague, 2nd Faculty of Medicine, Prague Czech Republic
1.13
Potential Predictors of Somnolence and Fatigue in Children with ADHD Treated with Clonidine Hydrochloride Extended-Release Tablets
Mark A. Stein, Ph.D.
University of Illinois at Chicago, Glencoe, IL
Matthew Brams, M.D.
Bayou City Research, Ltd., Houston, TX
Chao Wang, Ph.D.
Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals), Florham Park, NJ
Mija Yoon, Pharm.D.
Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals), Florham Park, NJ
Paul F. Cavanaugh, Ph.D.
Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals), Florham Park, NJ
Rafael Muniz, M.D.
Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals), Florham Park, NJ
1.14
DAT1 3'UTR VNTR Genotype, ADHD Symptoms, and Dexmethylphenidate Dose Response
Mark A. Stein, Ph.D.
University of Illinois at Chicago, Glencoe, IL
Jeffrey Newcorn, M.D.
Mount Sinai Medical Center, New York, NY
Irwin D. Waldman, Ph.D.
Emory University, Atlanta, GA
Beth Krone, M.S.
Mount Sinai Medical Center, New York, NY
Edwin H. Cook, M.D.
University of Illinois at Chicago, Chicago, IL
1.15
Metabolic Side Effects and the Interaction of Second-Generation Antipsychotics (SGA) with Leptin, Ghrelin, and Adiponectin in Children and Adolescents Naïve-Patients After 6 Months of Treatment with the Most Commonly Prescribed SGA
Cecilia Tapia, M.S.C.
Hospital General Universitario Gregorio Marañon de Madrid, Madrid Spain
Laura Pina-Camacho, M.D.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Pamela Rodriguez, B.S.
Hospital General Universitario Gregorio Marañon de Madrid, Madrid Spain
Jessica Merchán-Naranjo, M.S.C.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Celso Arango, M.D., Ph.D.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
1.16
National Trends in Pediatric Use of Anticonvulsants: On and Off-Label
Allen R. Tran, B.S.
University of Maryland, Baltimore, Baltimore, MD
Julie M. Zito, Ph.D.
University of Maryland, Baltimore, Baltimore, MD
Daniel J. Safer, M.D.
Johns Hopkins University School of Medicine, Baltimore, MD
Sarah Hundley, B.A.
University of Maryland, Baltimore, Baltimore, MD
1.17
The Clinical Impact of Switching ADHD Patients From OROS®-MPH to Novo-MPH ER-C®; A Pediatric Practice Review
Judy P.M. van Stralen, M.D., FRCPC
JPM van Stralen Medicine Professional Corporation, Ottawa, ON
1.18
Initial Experiences in a Randomized, Placebo-Controlled Trial of D-Cycloserine for the Enhancement of Social Skills Training in Pervasive Developmental Disorders
Logan Wink, M.D.
Indiana University School of Medicine, Indianapolis, IN
Sarah Hurwitz, Ph.D.
Indiana University School of Medicine, Indianapolis, IN
Stacie Pozdol, M.S.
Pozdol Behavior Therapy, LLC, Indianapolis, IN
Noha Minshawi, Ph.D.
Indiana University School of Medicine, Indianapolis, IN
Naomi Swiezy, Ph.D.
Indiana University School of Medicine, Indianapolis, IN
Craig A. Erickson, M.D.
Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN
Kimberly A. Stigler, M.D.
Indiana University School of Medicine, Indianapolis, IN
David J. Posey, M.D.
Indiana University School of Medicine, Indianapolis, IN
Christopher J. McDougle, M.D.
Indiana University School of Medicine, Indianapolis, IN
1.20
Discontinuation Rates and Side Effects in Treatment-Naïve Children and Adolescents Receiving Second-Generation Antipsychotics in a 6-Month Follow-up Study
Teresa Sanchez-Gutiérrez, M.S.C.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Marta Rapado-Castro, Ph.D.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Laura Pina-Camacho, M.D.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Jessica Merchán-Naranjo, M.S.C.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Cristina García-Mauriño Alcázar, B.S.
Universidad Complutense de Madrid, Madrid Spain
Celso Arango, M.D., Ph.D.
Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
1.21
Non-Clinical Factors Associated with Preschool Psychopharmacological Treatment
Mary-Margaret Gleason, M.D.
Tulane University School of Medicine, New Orleans, LA
Lizheng Shi, Ph.D.
Tulane University School of Tropical Medicine and Public Health, New Orleans, LA
Jinan Liu, M.P.H.
Tulane University, New Orleans, LA
1.22
Agonist Therapy for Methamphetamine Abuse: Is Around the Clock D-Amphetamine Safe?
Paul E. A. Glaser, M.D., Ph.D.
University of Kentucky, Lexington, KY
Josh A. Lile, Ph.D.
University of Kentucky, Lexington, KY
William W. Stoops, Ph.D.
University of Kentucky, Lexington, KY
Craig R. Rush, Ph.D.
University of Kentucky, Lexington, KY
1.23
Improving Quality of Care for Youth with ADHD: Components of Successful Medication Intervention
Sarah S. Grover, B.S.
Seattle Children's Research Institute, Seattle, WA
Carol M. Rockhill, M.D., M.P.H., Ph.D.
University of Washington School of Medicine, Seattle, WA
Gina M. Kim, B.A.
Seattle Children's Research Institute, Seattle, WA
Meghan Swardstrom
Seattle Children's Research Institute, Seattle, WA
Ann Vander Stoep, Ph.D.
University of Washington School of Medicine; University of Washington School of Public Health, Seattle, WA
Kathleen Myers, M.D., M.P.H.
University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA
1.24
Effects of Clonidine Extended Release on Oppositional Symptoms in Children Aged 6-17 Years with ADHD and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial
H. Joseph Horacek, M.D.
Center For Neurological Health In Learning, Charlotte, NC
1.25
Effects of STX209 (arbaclofen) on Social and Communicative Function in Autism Spectrum Disorder: Results of an 8-Week Open-Label Trial
Craig A. Erickson, M.D.
Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN
Lawrence Ginsberg, M.D.
Red Oak Psychiatry Associates, Houston, TX
Jeremy Veenstra-VanderWeele, M.D.
Kennedy Center for Research on Human Development, Nashville, TN
Raun Melmed, M.D.
Southwest Autism Research and Resource Center, Scottsdale, AZ
Linmarie Sikich, M.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
Lawrence Scahill, M.S.N., Ph.D.
Yale Child Study Center, New Haven, CT
James T. McCracken, M.D.
Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
Barbara Rathmell, M.D.
Seaside Therapeutics, Inc., Cambridge, MA
Randall L. Carpenter, M.D.
Seaside Therapeutics, Inc., Cambridge, MA
Paul Wang, M.D.
Seaside Therapeutics, Inc., Cambridge, MA
Mark Bear, Ph.D.
The Picower Institute for Learning and Memory, Cambridge, MA
Bryan H. King, M.D.
University of Washington, Seattle Children's Hospital, Seattle, WA
1.26
Measuring Parent Attitudes to Medication: Preliminary Data on a New Scale
Daniel J. Coletti, Ph.D.
Zucker Hillside Hospital, North Shore-LIJ Health System, Glen Oaks, NY
Hara Stephanou, B.A.
Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY
Brendan J. Graziano, B.A.
Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY
Peter S. Jensen, M.D.
Mayo Clinic; The REACH Institute, New York, NY
Suzanne Sunday, Ph.D.
Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY
Elizabeth Pappadopulos, Ph.D.
Pfizer Inc, Essex Fells, NJ
Vivian Kafantaris, M.D.
The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY
1.27
Discontinuation Study for Adolescent Depression
Amy Cheung, M.D.
Sunnybrook Health Sciences Centre, Toronto, ON
Anthony Levitt, M.D., FRCPC
Sunnybrook Health Sciences Centre, Toronto, ON
Stan Kutcher, M.D.
Dalhousie University, Izaak Walton Killam Health Centre, Halifax, NS
Michael Cheng, M.D.
Department of Psychiatry, Ottawa, ON
Derek Puddester, M.D.
Children's Hospital of Eastern Ontario, Ottawa, ON
Elyse Dubo, M.D.
Sunnybrook Health Sciences Centre, Toronto, ON
Margaret Weiss, M.D., FRCPC, Ph.D.
University of British Columbia, Vancouver, BC
Darcy Santor, Ph.D.
University of Ottawa, Ottawa, ON
Alex Kiss, Ph.D.
Sunnybrook Health Sciences Centre, Toronto, ON
1.28
A Double-Blind, Randomized, Placebo-Controlled Long-Term Study of Aripiprazole in Children with Bipolar Disorder
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Cleveland, OH
Eric Youngstrom, Ph.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
Nora K. McNamara, M.D.
Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH
Robert J. Stansbrey, M.D.
Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH
Christine A. Demeter, M.A.
Case Western Reserve University School of Medicine, Cleveland, OH
Brieana M. Rowles, M.A.
Case Western Reserve University School of Medicine, Cleveland, OH
Thomas W. Frazier, Ph.D.
Cleveland Clinic, Cleveland, OH
Joseph R. Calabrese, M.D.
Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH
1.30
Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have ADHD and Clinically Significant Deficits in Emotional Control
Alain Katic, M.D.
, Houston, TX
Rakesh Jain, M.D.
R/D Clinical Research, Inc., Lake Jackson, TX
Bryan Dirks, M.D.
Shire Development Inc., Wayne, PA
Thomas F. Babcock, D.O.
Shire Development Inc., Wayne, PA
Brian Scheckner, Pharm.D.
Shire Development Inc., Wayne, PA
Ben Adeyi, M.S.
Shire Development Inc., Wayne, PA
Cynthia Richards, M.D.
Shire Development Inc., Wayne, PA
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Cleveland, OH
1.32
Second Generation Antipsychotic (Risperidone) Increases Osteoclast Activity and Bone Resorption in Young C57BL/6 Mice
Katie Motyl, Ph.D.
Maine Medical Center Research Institute, Scarborough, ME
Ingrid Dick-dePaula, M.D.
University of Sao Paulo, São Paulo Brazil
Ann E. Maloney, M.D.
University of Massachusetts Medical School, Worcester, MA
Sutada Lotinun, Ph.D.
Harvard School of Dental Medicine, Boston, MA
Deborah Barlow, B.S.
University of New England, Portland, ME
Karen Houseknecht, Ph.D.
University of New England, Portland, ME
Rowland Baron, Ph.D.
Harvard University, Boston, MA
Linmarie Sikich, M.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
Clifford Rosen, M.D.
Maine Medical Center Research Institute, Scarborough, ME
1.33
Longer-Term Outcomes for Youth with Psychosis
Ann E. Maloney, M.D.
University of Massachusetts Medical School, Worcester, MA
Renee White, M.S.W.
Carolina Outreach, Durham, NC
Abigail Judge, Ph.D.
University of North Carolina Chapel Hill, Chapel Hill, NC
Lori Travis, M.S.
Maine Medical Center Research Institute, Portland, ME
Linmarie Sikich, M.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
1.34
Cognitive Functioning in Adolescents with Schizophrenia Treated with Paliperidone: Interim Data From a 6-Month, Open-Label Study
Gahan Pandina, Ph.D.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Timothy J. Petersen, Ph.D.
Massachusetts General Hospital, Topsfield, MA
Jaskaran Singh, M.D.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Ujjwala Vijapurkar, Ph.D.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
David Hough, M.D.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
1.36
A Randomised Controlled Trial of Computerized Cognitive Behavioral Therapy for Adolescents with Depression
Sally N. Merry, M.D., F.R.A.N.Z.C.P., M.B.Ch.B.
The Werry Centre for Child and Adolescent Mental Health, Auckland New Zealand
Karolina Stasiak, Ph.D.
Werry Centre for Child and Adolescent Mental Health, Auckland New Zealand
Chris Frampton, Ph.D.
University of Otago, Christchurch New Zealand
Matt Shepherd, B.A., B.S.
Werry Centre for Child and Adolescent Mental Health, Auckland New Zealand
Mathijs Lucassen, Sc.M.
Werry Centre for Child and Adolescent Mental Health, Auckland New Zealand
Theresa Fleming, B.A., M.S.
Werry Centre for Child and Adolescent Mental Health, Auckland New Zealand
1.38
A Typological Approach of Obsessive Compulsive Symptoms at Young Age: Personality Correlates and Longitudinal Associations with Depression and Quality of Life
Elien De Caluwé
Ghent University, Ghent Belgium
Marleen De Bolle, Ph.D.
Ghent University, Ghent Belgium
Barbara De Clercq, Ph.D.
Ghent University, Ghent Belgium
1.39
International Obsessive Compulsive Disorder Foundation Genetics Collaborative Genomewide Association Study of Obsessive Compulsive Disorder
S. Evelyn Stewart, M.D.
University of British Columbia; Harvard Medical School, Vancouver, BC
Dongmei Yu, M.S.
Massachusetts General Hospital, Boston, MA
Jeremiah Scharf, M.D., Ph.D.
Massachusetts General Hospital, Boston, MA
Eric R. Gamazon, M.S.C.
University of Chicago, Chicago, IL
Patrick D. Evans, Ph.D.
University of Chicago, Chicago, IL
James A. Knowles, M.D., Ph.D.
University of Southern California, Los Angeles, CA
Carol A. Mathews, M.D.
University of California, San Francisco, Langley Porter Psychiatric Institute, San Francisco, CA
Paul Arnold, M.D., FRCPC, Ph.D.
The Hospital for Sick Children, Toronto, ON
Gregory L. Hanna, M.D.
University of Michigan, Ann Arbor, MI
Gerald Nestadt, M.D., M.P.H.
Johns Hopkins Medical Institutions, Baltimore, MD
Michael Wagner, M.D.
University of Bonn, Bonn Germany
Damiaan Denys, M.D., Ph.D.
AMC (University of Amsterdam), Amsterdam Netherlands
Danielle C. Cath, M.D.
Utrecht University; VU University Medical Center, Utrecht Netherlands
Christine Lochner, Ph.D.
University of Stellenbosch, Cape Town South Africa
Dennis L. Murphy, M.D.
National Institute of Mental Health, Bethesda, MD
Ana G. Hounie, M.D., Ph.D.
University of Sao Paulo, São Paulo Brazil
Maria Cristina Cavallini, M.D.
Fondazione Centro San Raffaele del Monte Tabor, Milan Italy
Humberto S. Nicolini, M.D., Ph.D.
Carracci Medical Group, Mexico City Mexico
Richard Delorme, M.D., Ph.D.
Robert Debre University Hospital, Paris France
Dan J. Stein, M.D.
University of Stellenbosch, Cape Town South Africa
Jack F. Samuels, Ph.D.
Johns Hopkins Hospital, Baltimore, MD
Euripedes C. Miguel, M.D.
University of Sao Paulo, São Paulo Brazil
Michael T. Pato, M.D., Ph.D.
University of Southern California, Los Angeles, CA
Jesen A. Fagerness, B.S., J.D.
Massachusetts General Hospital, Boston, MA
Catherine Mayerfeld, B.A.
Massachusetts General Hospital, Boston, MA
Stephen A. Haddad, M.D.
Massachusetts General Hospital, Boston, MA
Benjamin M. Neale, Ph.D.
The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA
Shaun Purcell, Ph.D.
Massachusetts General Hospital; Harvard Medical School, Boston, MA
Nancy Cox, Ph.D.
University of Chicago, Chicago, IL
David Pauls, Ph.D.
Massachusetts General Hospital, Boston, MA
1.40
Clinical Correlates and Specific Symptom Predictors of Family Functioning Impairment in Obsessive Compulsive Disorder
Yupei P. Hu, M.D.
McLean Hospital, Belmont, MA
Michael A. Jenike, M.D.
Massachusetts General Hospital, Boston, MA
Daniel A. Geller, M.D.
Massachusetts General Hospital, Newton, MA
David Pauls, Ph.D.
Massachusetts General Hospital, Boston, MA
S. Evelyn Stewart, M.D.
University of British Columbia; Harvard Medical School, Vancouver, BC
1.41
Psychiatric Disorders in Children of Depressed Parents: Characteristics Impacting Outcome
Lisa A. Batten, M.A.
University of Ottawa Institute of Mental Health Research, Ottawa, ON
Priya Wickramaratne, Ph.D.
Columbia University, New York, NY
Mariely Hernandez, M.A.
Lucio Bini Mood Disorders Center, New York, NY
Delphie Dugal-Tessier, B.A.
University of Ottawa, Ottawa, ON
Phil Adams, Ph.D.
Columbia University, New York, NY
Martine F. Flament, M.D., FRCPC, Ph.D.
University of Ottawa Institute of Mental Health Research, Ottawa, ON
Daniel Pilowsky, M.D.
Mailman School of Public Health at Columbia University, New York, NY
Pierre Tessier, M.D.
University of Ottawa Institute of Mental Health Research, Ottawa, ON
Patrick McGrath, M.D.
New York State Psychiatric Institute, New York, NY
Jonathan Stewart, M.D.
Columbia University, New York, NY
Pierre Blier, M.D., Ph.D.
University of Ottawa Institute of Mental Health Research, Ottawa, ON
Myrna Weissman, Ph.D.
Columbia University, New York, NY
1.43
Preschool Psychopathology: Rates, Comorbidity, and Stability of
DSM-IV Disorders
Sara J. Bufferd, M.A.
Stony Brook University, Stony Brook, NY
Lea R. Dougherty, Ph.D.
University of Maryland, College Park, College Park, MD
Daniel N. Klein, Ph.D.
Stony Brook University, Stony Brook, NY
Gabrielle A. Carlson, M.D.
Stony Brook University, Stony Brook, NY
1.44
Parenting and Child Depressive Symptoms: The Moderating Role of Emotion Regulation and Competence
Adriana Guerrero, B.A.
Northwestern University Feinberg School of Medicine, Chicago, IL
Hannah B. Chapel, B.A.
Northwestern University Feinberg School of Medicine, Chicago, IL
Carri Hill, Ph.D.
Northwestern University Feinberg School of Medicine, Chicago, IL
Barbara Danis, Ph.D.
Northwestern University Feinberg School of Medicine, Chicago, IL
Lauren S. Wakschlag, Ph.D.
Northwestern University Feinberg School of Medicine, Chicago, IL
1.45
Personality Disorder Symptoms in Offspring of Mothers with Bipolar Disorder, with Major Depression, and with Neither Diagnosis
Kathryn R. Cullen, M.D.
University of Minnesota Medical School, Minneapolis, MN
Bonnie Klimes-Dougan, Ph.D.
University of Minnesota, Minneapolis, MN
Monika Heller, M.D.
University of Minnnesota Medical School, Minneapolis, MN
Lynn E. Eberly, Ph.D.
University of Minnesota, Minneapolis, MN
Philip W. Gold, M.D.
National Institute of Mental Health, Bethesda, MD
Pedro E. Martinez, M.D.
National Institute of Mental Health, Bethesda, MD
1.46
Tics, Inattention, Hyperactivity, Obsessions: Which Contributes to Parent-Reported Internalizing, Externalizing, and Social Problems Among a Clinical Sample of Pediatric Patients with Tic Disorders?
Katherine K. Dahlsgaard, Ph.D.
The Children's Hospital of Philadelphia, Philadelphia, PA
Stacey Krauss, M.S.
Brooke Army Medical Center Clinical Internship Program, San Antonio, TX
Cristina Shaheen, M.S.
The Children's Hospital of Philadelphia, Philadelphia, PA
Anthony Leon Rostain, M.D.
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
1.47
Adolescent Self-Injury: Personality Traits, Family Relationships, and Maltreatment on Presence and Severity of Behaviors
Rossella Di Pierro
University of Milan-Bicocca, Milan Italy
Irene Sarno, Ph.D.
University of Milan-Bicocca, Milan Italy
Sara Perego
University of Milan-Bicocca, Milan Italy
Marcello Gallucci, Ph.D.
University of Milan-Bicocca, Milan Italy
Fabio Madeddu, M.D.
University of Milan-Bicocca, Milan Italy
1.48
Is ADHD a Risk Factor for High School Dropout? A Controlled Study
Ronna Fried, Ed.D.
Massachusetts General Hospital, Boston, MA
Carter R. Petty, M.A.
Massachusetts General Hospital, Boston, MA
Laran Hyder, B.A.
Massachusetts General Hospital, Boston, MA
Elizabeth Pinsky, M.D.
Massachusetts General Hospital, Boston, MA
Helen Day, B.A.
Massachusetts General Hospital, Boston, MA
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
1.49
Problem Behavior in Children Born to Mothers with Thyroid Autoimmunity During Pregnancy: The Generation R Study
Akhgar Ghassabian, M.D.
Erasmus Medical Center, Sophia Children's Hospital, Rotterdam Netherlands
Vincent W. V. Jaddoe, M.D., Ph.D.
Erasmus Medical Center, Rotterdam Netherlands
Frank C. Verhulst, M.D., Ph.D.
Erasmus Medical Center, Sophia Children's Hospital, Rotterdam Netherlands
Theo J. Visser, M.D., Ph.D.
Erasmus Medical Center, Rotterdam Netherlands
Henning Tiemeier, M.D., Ph.D.
Erasmus Medical Center, Rotterdam Netherlands
1.50
Intra-Subject Variability of Response Times in Children with ADHD and Autism Spectrum Disorder Compared to a Group of Healthy Controls
Nicoletta Adamo, M.D.
Child Study Center - Institute of Pediatric Neuroscience, New York, NY
Sarah B. Lebovitz, B.A.
Institute for Pediatric Neuroscience, New York, NY
Lei Huang, M.A.
Institute for Pediatric Neuroscience, New York University Child Study Center, New York, NY
Eva Petkova, Ph.D.
New York University Child Study Center, Institute for Pediatric Neuroscience, New York, NY
F. Xavier Castellanos, M.D.
New York University Langone Medical Center, New York, NY
Adriana Di Martino, M.D.
New York University Langone Medical Center, New York, NY
1.51
Macrocephaly and Autism Spectrum Disorders: Results From a California Twin Study
Wendy Froehlich, M.D.
Stanford University, Mountain View, CA
Sue Cleveland, B.S.
Stanford University, Stanford, CA
Andrea Torres, M.A.
Stanford University, Stanford, CA
Jennifer Phillips, Ph.D.
Stanford University, Stanford, CA
Brianne Cohen, B.A.
Autism Genetic Resource Exchange, Los Angeles, CA
Tiffany Torigoe, B.A.
Autism Genetic Resource Exchange, Los Angeles, CA
Janet Miller, Ph.D.
Autism Genetic Resource Exchange, Los Angeles, CA
Angie Fedele, B.A.
Autism Genetic Resource Exchange, Los Angeles, CA
Jack Collins, M.B.A.
Kaiser Permanente, Oakland, CA
Karen Smith, B.S.
California Department of Public Health, Richmond, CA
Linda J. Lotspeich
Stanford University, Stanford, CA
Lisa Croen, Ph.D.
Kaiser Permanente, Oakland, CA
Sally Ozonoff, Ph.D.
University of California, Davis Medical Investigation of Neurodevelopmental Disorders Institute, Sacramento, CA
Clara Lajonchere, Ph.D.
Autism Speaks, Los Angeles, CA
Judith Grether, Ph.D.
California Department of Public Health, Richmond, CA
Neil Risch, Ph.D.
University of California, San Francisco, San Francisco, CA
Joachim Hallmayer, M.D.
Stanford University, Stanford, CA
1.52
Examining the Longitudinal Associations Among Maternal Depression, Parental Inconsistency, Inhibitory Control, and Attention Problems in Preschool Children
Miriam M. Martinez, M.A.
University of Nebraska-Lincoln, Lincoln, NE
Jennifer Mize Nelson, Ph.D.
University of Nebraska-Lincoln, Lincoln, NE
Tiffany D. Sheffield, M.A.
University of Nebraska-Lincoln, Lincoln, NE
Kimberly A. Espy, Ph.D.
University of Nebraska-Lincoln, Lincoln, NE
1.53
The Role of Infant Temperament in Predicting Childhood Psychiatric Disorder: Longitudinal Study
Kapil S. Sayal, M.R.C.Psych., Ph.D.
University of Nottingham, Nottingham United Kingdom
Jon Heron, Ph.D.
University of Bristol, Bristol United Kingdom
Barbara Maughan, Ph.D.
King's College London, London United Kingdom
Richard Rowe, Ph.D.
University of Sheffield, Sheffield United Kingdom
Paul Ramchandani, D.Phil., M.R.C.Psych.
University of Oxford, Oxford United Kingdom
1.54
Examining the Relationship Between Tic Disorders, Comorbid Diagnoses, and Functional Competence in Pediatric Outpatients
Cristina Shaheen, M.S.
The Children's Hospital of Philadelphia, Philadelphia, PA
Katherine K. Dahlsgaard, Ph.D.
The Children's Hospital of Philadelphia, Philadelphia, PA
Anthony Leon Rostain, M.D.
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
1.55
Behavioral Indicators of Coping and Mental Health in Sexually Abused Children
Danielle N. Shapiro, M.S.
University of Michigan, Ann Arbor, MI
Julie B. Kaplow, A.B.P.P., Ph.D.
University of Michigan, Ann Arbor, MI
Kenneth A. Dodge, Ph.D.
Duke University, Durham, NC
Lisa Amaya-Jackson, M.D., M.P.H.
Duke University Medical Center, Durham, NC
1.56
Development of Korean Version of Behavior Assessment System for Children, Second Edition, Parent Rating Scale-Child (K-BASC-2 PRS-C)
Jungeun Song, M.D.
Myungji Hospital, Kwandong University, Goyang Si South Korea
Yun-Joo Koh, Ph.D.
The Korea Institute for Children's Social Development, Seoul South Korea
Keun-Ah Cheon, M.D., Ph.D.
Severance Children's Hospital, Yosei University College of Medicine, Seoul South Korea
Hyun Ju Hong, M.D.
Hallym University Sacred Heart Hospital, Anyang Kyunggi-do South Korea
Young-Key Kim, M.D.
National Health Insurance Corporation Ilsan Hospital, Seoul South Korea
Bennett L. Leventhal, M.D.
Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Eun-Chung Lim, M.A.
The Korea Institute for Children's Social Development; Rudolph Child Research Center South Korea
Kyungun Jhung, M.D.
Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Kyungjin Cho, Ph.D.
The Cyber University of Korea, Seoul South Korea
Young-Shin Kim, M.D., M.P.H., M.S., Ph.D.
Yale Child Study Center, Branford, CT
1.58
Findings From N-MAPSS: Past 30-Day Nonmedical Use of Prescription Stimulants in 10-18 Year Olds
Michelle D. Ertischek, M.P.H.
PinneyAssociates, Bethesda, MD
Susan Bradford, B.S.
Washington University School of Medicine in St. Louis, Saint Louis, MO
Mark A. Sembower, M.S.
PinneyAssociates, Pittsburgh, PA
Sidney Schnoll, M.D., Ph.D.
PinneyAssociates, Bethesda, MD
Linda Cottler, M.P.H., Ph.D.
Washington University in St. Louis, Saint Louis, MO
1.59
Comparative Study of Psychopathology in Offspring of Parents with and without Bipolar Disorder
Patricia Zavaleta-Ramírez, M.D.
National Institute of Psychiatry Ramón de la Fuente, México City Mexico
Francisco De la Peña, M.D., M.S.C.
National Institute of Psychiatry Ramón de la Fuente, Distrito Federal Mexico
Miriam Feria, M.D.
National Institute of Psychiatry Ramón de la Fuente, Distrito Federal Mexico
Liz Sosa, M.D.
National Institute of Psychiatry Ramón de la Fuente, Distrito Federal Mexico
Adriana Arias Caballero, M.R.C.Psych.
National Institute of Psychiatry Ramón de la Fuente, Distrito Federal Mexico
Claudia Becerra, M.D., M.S.C.
National Institute of Psychiatry Ramón de la Fuente, México City Mexico
Lino Palacios, M.D.
National Institute of Psychiatry Ramón de la Fuente, Mexico City Mexico
1.60
Does Early Mentorship in Child and Adolescent Psychiatry Make a Difference? The Klingenstein Third Generation Foundation Medical Student Training Program
Joshua Stein, B.A.
Mount Sinai School of Medicine, New York, NY
Alexander Kolevzon, M.D.
Mount Sinai School of Medicine, Seaver Autism Center, New York, NY
KTGF National Network
The Klingenstein Third Generation Foundation Medical Student Training Program, New York, NY
AACAP Department of Research, Training and Education
American Academy of Child & Adolescent Psychiatry, Washington, DC
